Neuren Pharmaceuticals (NEU) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Why Core Lithium, Healius, Neuren, and Reject Shop shares are storming higher todayMarch 27, 2025 | msn.comMeet the dirt cheap ASX 200 stock that could rocket 75%March 12, 2025 | msn.comCanaccord Genuity Keeps Their Buy Rating on Neuren Pharmaceuticals Limited (NURPF)March 7, 2025 | markets.businessinsider.comNeuren Pharmaceuticals Full Year 2024 Earnings: Beats ExpectationsMarch 4, 2025 | finance.yahoo.comNews Flash: 6 Analysts Think Neuren Pharmaceuticals Limited (ASX:NEU) Earnings Are Under ThreatMarch 1, 2025 | finance.yahoo.comWhy Eagers, Medibank, Neuren, and Qantas shares are jumping todayFebruary 26, 2025 | msn.comWhy APA, Aussie Broadband, Neuren, and NIB shares are charging higher todayFebruary 23, 2025 | msn.com2 ASX 200 pharmaceutical shares surging on big US newsFebruary 18, 2025 | msn.comNeuren Pharmaceuticals Limited's (ASX:NEU) Stock's On An Uptrend: Are Strong Financials Guiding The Market?January 21, 2025 | finance.yahoo.comInvest $10,000 into these ASX 200 shares in JanuaryJanuary 5, 2025 | fool.com.auNeuren Pharmaceuticals Ltd NURPFDecember 21, 2024 | morningstar.comNeuren Pharmaceuticals Boosts Buy-Back ProgramDecember 12, 2024 | markets.businessinsider.comNeuren Pharmaceuticals Limited's (ASX:NEU) Intrinsic Value Is Potentially 60% Above Its Share PriceDecember 5, 2024 | finance.yahoo.comScott Power: S&P/ASX 200 Health Care Index falls but which stocks are up on positive news?November 15, 2024 | msn.comNeuren Pharmaceuticals’ Commitment to Neurodevelopmental CareNovember 15, 2024 | markets.businessinsider.comNeuren Pharmaceuticals Unveils A$50 Million Share Buy-BackNovember 14, 2024 | markets.businessinsider.comBuy this ASX 200 share that is swimming in cashNovember 12, 2024 | msn.comCanaccord Genuity Remains a Buy on Neuren Pharmaceuticals Limited (NURPF)November 11, 2024 | markets.businessinsider.comASX 200 healthcare stock rockets on $75 million newsNovember 7, 2024 | msn.comNeuren Pharmaceuticals Reports Strong Q3 Financial GrowthNovember 7, 2024 | markets.businessinsider.comThese ASX 200 growth shares could rise 65% and 100%October 29, 2024 | msn.comHere's Why We Think Neuren Pharmaceuticals (ASX:NEU) Might Deserve Your Attention TodayOctober 22, 2024 | finance.yahoo.comWhy AMP, Neuren, Ora Banda, and Paladin Energy shares are storming higher todayOctober 17, 2024 | msn.comWilsons Sticks to Its Buy Rating for Clarity Pharmaceuticals Ltd. (CU6)October 15, 2024 | markets.businessinsider.comWhy Elixir Energy, Neuren, Reece, and TechnologyOne shares are tumbling todayOctober 8, 2024 | msn.comGuess which ASX 200 healthcare stock is charging higher following FDA updateOctober 6, 2024 | msn.comNeuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndromeOctober 6, 2024 | msn.comAngelman Syndrome (AS) Market Assessment 2024: US and EU5 Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & AccessSeptember 27, 2024 | finance.yahoo.comCanaccord Genuity Sticks to Their Buy Rating for PYC Therapeutics Limited (PYC)September 23, 2024 | markets.businessinsider.comNeuren Pharmaceuticals Limited (NURPF) Receives a Buy from Canaccord GenuitySeptember 23, 2024 | markets.businessinsider.comAnalysts think these ASX 200 shares are strong buysSeptember 22, 2024 | msn.comThese ASX 200 shares could rise ~40% to 75%September 21, 2024 | fool.com.auThe five pharma stocks exciting investorsSeptember 20, 2024 | afr.com4 ASX healthcare stocks having a cracking run on FridaySeptember 19, 2024 | msn.comThose who invested in Neuren Pharmaceuticals (ASX:NEU) three years ago are up 576%September 18, 2024 | finance.yahoo.comNeuren Pharmaceuticals Ltd Annual Shareholders Meeting TranscriptSeptember 14, 2024 | gurufocus.comNeuren Pharmaceuticals Ltd Investor Webinar TranscriptSeptember 14, 2024 | gurufocus.comBuy Hold Sell: 3 stocks that have been smashed (and 2 big buys)September 7, 2024 | msn.comWhy the Super Micro Computer filing delay spooked investorsAugust 29, 2024 | nz.finance.yahoo.comJefferies Sticks to Their Buy Rating for Neuren Pharmaceuticals Limited (NURPF)August 28, 2024 | markets.businessinsider.comPipeline Moves: Moderna’s pandemic influenza vaccine trial completesAugust 19, 2024 | finance.yahoo.comThese ASX shares could rise 20% to 60%August 18, 2024 | msn.comAnalysts Offer Insights on Healthcare Companies: Kodiak Sciences (KOD) and Pro Medicus Limited (OtherPMCUF)August 15, 2024 | markets.businessinsider.comNeuren Pharmaceuticals Limited's (ASX:NEU) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?August 15, 2024 | finance.yahoo.comNeurotech focuses on global partnerships and Aussie registrationAugust 12, 2024 | msn.comWhy Light & Wonder, Neuren, Nick Scali, and QBE shares are falling todayAugust 9, 2024 | msn.comWhy are Neuren Pharmaceuticals shares crashing 9%?August 9, 2024 | msn.comAussie shares move higher again as dip-buyers step inAugust 7, 2024 | msn.comThis ASX stock could rise 60%+August 6, 2024 | msn.com3 of the best ASX 200 shares to buy in AugustAugust 5, 2024 | msn.com Remove Ads Get Neuren Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NEU and its competitors with MarketBeat's FREE daily newsletter. Email Address NEU Media Mentions By Week NEU Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NEU News Sentiment▼0.000.62▲Average Medical News Sentiment NEU News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NEU Articles This Week▼01▲NEU Articles Average Week Remove Ads Get Neuren Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NEU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Arcadium Lithium News Today Element Solutions News Today CSW Industrials News Today Polar Capital Technology Trust News Today Avient News Today Methanex News Today Chemours News Today Perimeter Solutions News Today Braskem News Today CVR Partners News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:NEU) was last updated on 4/6/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | SponsoredControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuren Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuren Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
